ODD just endured its worst week in years — and the Street's response has been swift, unified, and unsparing.
The stock closed Tuesday at $9.84, down 30% in a single session on June 2 and 19% on the week after Q1 results triggered a brutal re-rating. What's notable today is not the price action itself — that story was told yesterday — but the wave of analyst revisions that followed. Goldman Sachs downgraded to Sell with an $8 target, cut from $16. Barclays, already at Underweight, slashed its target from $13 to $8. Morgan Stanley held its Equal-Weight rating but dropped its target from $16 to $10. Keybanc moved to Sector Weight from Overweight. That is four major firms moving against the stock in a single morning, with consensus now firmly in hold-to-sell territory and a mean price target of just $11.09 — barely 13% above the current price.
The bull and bear cases have rarely been more starkly opposed. Bears point to a 38.7% sequential revenue decline in Q1, a 59% collapse in operating income, a 17.5% year-on-year drop in adjusted EBITDA, and — most damaging — management's decision to withhold full-year 2026 guidance, citing disruption from the company's largest advertising partner. The absence of guidance removes the valuation floor that growth investors typically rely on. Bulls counter that the DTC business still grew 24.3% year-on-year, gross margins expanded to 71.6%, and the FY25 gross margin guidance was raised to roughly 72.5%. The underlying brand economics, they argue, are intact even if near-term revenue is impaired. With EV/EBITDA at 8.6x and a P/B ratio below 0.9x, the stock is no longer priced for growth — but it is not obviously cheap for a business that just withdrew forward visibility.
The borrow market tells a complementary story to the analyst pile-on. As covered in Tuesday's note, availability had compressed to just 3.7% on June 1 — the tightest level in at least a year — before recovering to 17.1% on June 2 as new supply entered the lending pool. That remains deeply tight by historical standards. Short interest has climbed to 13.3% of free float, up 12% on the week and nearly 15% over the past month. The cost to borrow has doubled in a month to 1.59% APR. The ORTEX short score is 70.5, up from 66.8 a week ago. Short sellers added conviction into the collapse — a pattern that usually reflects a structural thesis rather than opportunistic momentum.
Options positioning offers a mild counterpoint. The put/call ratio is 0.51, slightly below its 20-day average of 0.55, and the z-score of -1.24 means options traders are not materially more defensive than recent norms — despite the severity of the drawdown. Call open interest is holding relative to puts. That is a somewhat surprising read: either options traders positioned defensively before the print and have since unwound, or there is residual call activity tied to speculative bounce positioning. Either way, options are not amplifying the bearish signal from short sellers and analysts.
On the institutional side, CEO Oran Holtzman holds 24.3% of shares outstanding, a stake large enough to act as an anchor against indiscriminate selling. Baillie Gifford — typically a long-duration growth holder — had 13.8% as of end-March and added 693,000 shares in Q1. Morgan Stanley Investment Management added 1.2 million shares in the same period. Those Q1 additions predate the Q1 results, so their current posture is unknown, but the presence of long-conviction holders creates a structural base. The CFO's recent trades — routine award-and-sell sequences totalling modest sums — carry no informational signal.
The next scheduled catalyst is the Q2 earnings call on August 4. Between now and then, the key variable to watch is whether management provides any interim update on the advertising disruption that caused Q1 guidance to be withdrawn — and whether short availability remains in tight territory or continues to normalise as the initial positioning frenzy settles.
See the live data behind this article on ORTEX.
Open ODD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
